Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06380491

Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)

Impact of Melatonin Treatment on Blood Pressure Circadian Rhythm, Sleep and Metabolic Variables.

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if melatonin works to treat comorbid insomnia in adults with OSA and nocturnal non-dipping blood pressure pattern. The main question it aims to answer is: Does melatonin maintain sleep during night and recover the dipping blood pressure pattern?

Detailed description

The goal of this clinical trial is to learn if melatonin works to treat comorbid insomnia in adults with OSA and nocturnal non-dipping blood pressure pattern. The main question it aims to answer is: Does melatonin maintain sleep during night and recover the dipping blood pressure pattern? Participants will: * Take melatonin or the habitual treatment every day for one month * Visit the clinic 11 times for one month * Keep a diary of their symptom and activities and use twice a 24 h ambulatory blood pressure monitoring (ABPM), attend two overnight polysomnography studies, and use an actigraph every day for 2 weeks. Researchers will compare melatonin to the habitual treatment to see if melatonin works to treat insomnia and recover the dipping blood pressure pattern. The medical problems that participants would have when taking melatonin are: * changes in blood pressure and cholesterol * Increased risk of contracting immune system disorders * Possible increased risk of liver damage.

Conditions

Interventions

TypeNameDescription
DRUGMelatonin 3 MG Oral TabletParticipants with OSA and nocturnal non-dipping Blood Pressure will be randomly assigned to a treatment with melatonin 3mg/d or to receive only the usual care.

Timeline

Start date
2023-06-22
Primary completion
2027-12-22
Completion
2028-01-22
First posted
2024-04-24
Last updated
2026-04-01

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT06380491. Inclusion in this directory is not an endorsement.